Diabetes Technology and Therapeutics Impact Factor, Indexing, Ranking
Diabetes Technology and Therapeutics (DTr) is a scholarly journal dedicated to publishing research in the field of Medicine. Mary Ann Liebert is the publisher of this esteemed journal.
The P-ISSN assigned to Diabetes Technology and Therapeutics is 1520-9156 and its abbreviated form is Dialogues Hum Geogr.
Diabetes Technology & Therapeutics is the only peer-reviewed journal providing healthcare professionals with information on new devices, drugs, drug delivery systems, and software for managing patients with diabetes. This leading international journal delivers practical information and comprehensive coverage of cutting-edge technologies and therapeutics in the field, and each issue highlights new pharmacological and device developments to optimize patient care.
Abbreviation :ISO Journal abbreviation refers to the shortened form or acronym used to represent the full title of a scholarly journal. The ISO4 Abbreviation of Diabetes Technology and Therapeutics Journal is Dialogues Hum Geogr.
The Ranking of the Journal in 2024 is 986. Ranking systems aim to provide an indication of a journal's quality, influence, and prestige within a specific field or discipline.
The Journal's Impact Factor in 2024 is 5.4. it is all calculated by Clarivate, which means how many times a particular citation has been published in the past two years.
The Journal SCImago in 2024 is 2.374. It is measured by the number of citations which are made by the particular journals, and the journal from where the citations arrived from.
The Journal's H-Index in 2024 is 97. The H-index is calculated on how many times a particular author is cited and the number of published papers that a particular author has.
The Journal's Quartile is Q1. A quartile has three points, which are the upper quartile, median, and lower quartile. The main motive of the quartile is to calculate the interquartile range, that resembles the changes across the median.
Indexing services aim to make it easier for researchers, scholars, and readers to discover and access articles from various journals within a specific field or discipline.
Processing/Submission Fee : Article submission/Processing fees (APC), also known as manuscript Publication fees or processing fees (APC), are charged by journals to authors for submitting/publishing their research papers/article.
The APC/Submission (Publication) Fee of the Journal is $3,600 USD
Publishing in Diabetes Technology and Therapeutics involves the following steps:
Research: Conduct high-quality, impactful research in the field of Medicine.
Familiarize Yourself: Read and understand the aims and scope of Diabetes Technology and Therapeutics to ensure your work aligns with their focus.
Manuscript Preparation: Prepare your manuscript according to the Diabetes Technology and Therapeutics guidelines, including formatting, length, and referencing style.
Submission: Submit your manuscript through the journal's online submission system.
No, the journal is not indexed in Index copernicus.
is a predatory journal?
No, journal is not a predatory journal.
What is the Imptact Factor of Diabetes Technology and Therapeutics?
The Impact Factor of the Journal is 5.4.
What is the Ranking of the Journal?
The Ranking of the Journal is 986.
is journal peer reviewed?
Yes the journal is a peer-reviewed journal.
is Diabetes Technology and Therapeutics a good journal?
Yes the journal is a peer-reviewed journal and good to publish your paper.
What is Diabetes Technology and Therapeutics?
Diabetes Technology and Therapeutics (DTr) is a scholarly journal dedicated to publishing research in the field of Medicine. Mary Ann Liebert is the publisher of this esteemed journal.
is Diabetes Technology and Therapeutics open access?
Yes, Diabetes Technology and Therapeutics is a open access (Hybrid) journal.